Skeletrophin Antibodies

Santa Cruz Biotechnology features a diverse variety of Skeletrophin Antibodies for investigating skeletrophin's role in cellular processes. Skeletrophin Antibodies are compatible with multiple research applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Skeletrophin, also known as SOSTDC1, plays a critical role in bone development and homeostasis by regulating the activity of osteoblasts and osteoclasts. Its importance extends to various physiological processes, including the modulation of Wnt signaling pathways, which are essential for bone formation and maintenance. Understanding skeletrophin function is vital for elucidating mechanisms underlying bone-related diseases and disorders. Researchers worldwide utilize skeletrophin monoclonal antibodies to advance bone development research and explore potential therapeutic approaches. Current investigations focus on how skeletrophin influences bone metabolism and tissue regeneration. Ongoing studies examine skeletrophin's involvement in skeletal disorders and potential therapeutic applications. Santa Cruz Biotechnology monoclonal antibodies for skeletrophin research continue to support scientific discoveries in bone biology and disease treatment.